Article
Impact of Simultaneous Circulating Tumor DNA and Tissue Genotyping in the Workup of Stage IV Lung Adenocarcinoma on Quality of Care in an Academic Community Medical Center.
JCO oncology practice - 1 Aug 2023
Maity Alisha P, Gangireddy Mounika, Degen Kathleen C, Al-Saleem Fetweh H, Bramson Joshua, Ciocca Vincenzo, Dessain Scott K, Evans Tracey L
Abstract excerpt
PURPOSE: In patients with metastatic lung adenocarcinoma, evidence-based first-line treatment decisions require analysis of tumors for genomic alterations (GAs). Optimizing the genotyping paradigm may improve the delivery of precision oncology care. Actionable GAs can be identified by analyzing tumor tissue or circulating tumor DNA using liquid biopsy. Consensus guidelines for when to use liquid biopsy have not...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.